Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Sunitinib (Sutent)|DRUG: Taxotere
Sponsor: Pfizer